FDA Inspection 1193468 — Esteve CDMO US, Inc.

Esteve CDMO US, Inc. — FEI 1416120

The FDA completed an inspection of Esteve CDMO US, Inc. on November 16, 2022 in Morton Grove, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 16, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Morton Grove, IL (United States)